デジタル処方箋の世界市場：2025年～2033年

世界のデジタル処方箋の市場規模は、2024年に23億1,000万米ドルに達し、2033年には183億9,000万米ドルに達するとみられ、2025年から2033年の予測期間中に23.4％のCAGRで拡大すると予測されています。

電子処方箋市場としても知られる世界のデジタル処方箋市場は、医療処方箋の作成、管理、保管、送信のための電子システムの使用を包含します。これらのシステムは、電子カルテ（EHR）や薬局管理システムと統合することで、処方箋の正確性を高め、投薬ミスを最小限に抑え、患者の安全性を向上させるように設計されています。

市場は主にソリューションとサービスの2つに分類されます。ソリューションには統合システムとスタンドアロンシステムがあり、サービスにはサポート＆メンテナンス、導入、ネットワークサービス、トレーニング、教育が含まれます。このうち統合型ソリューションは、電子カルテ（EHR）や病院管理システムとのシームレスな相互運用性により、ワークフローの効率を向上させることができるため、圧倒的なシェアを占めています。

Webおよびクラウドベースのソリューションは、その拡張性、費用対効果、リモートアクセス性により、急速な成長を遂げています。オンプレミス・ソリューションは、特にデータ・セキュリティと規制遵守が最優先事項である大規模ヘルスケア機関の間で、引き続き市場で強い存在感を示しています。

電子カルテ（EHR）ソリューションの採用増加は、世界のデジタル処方箋市場の成長を大きく後押ししており、市場予測期間を通じて成長を牽引すると予想されます。EHRは、患者データを保存、検索、共有するための一元化されたデジタルプラットフォームとして機能し、ヘルスケアプロバイダーが医療記録をより効率的に管理できるようにします。電子処方システムとの統合により、処方の正確性が向上し、投薬ミスが減少し、全体的なワークフローの効率が高まります。

EHRは電子処方システムと同期するように設計されており、薬歴、アレルギー、検査結果などの重要な患者データがすぐに利用できるようになっています。このようにリアルタイムでデータにアクセスできるため、処方ミスが減り、医師はより多くの情報に基づき、データ主導で処方を決定することができます。EHRとデジタル処方箋システムの相互運用性は、医師、薬剤師、ヘルスケア機関の間の治療連携を強化し、全体的な患者の安全性と治療成果を向上させます。

データセキュリティーとプライバシーの懸念は、主に関連する患者情報の機密性のため、世界のデジタル処方箋市場の成長を妨げるでしょう。デジタル処方箋は電子データ送信に大きく依存しているため、潜在的なデータ漏洩、不正アクセス、サイバー攻撃のリスクが生じます。処方箋には、患者の薬歴、アレルギー、個人の健康状態などの機密情報が含まれています。このようなデータを電子的に保存・送信することは、患者情報の機密性と完全性に関する懸念を生じさせます。

ヘルスケアプロバイダーやテクノロジー企業は、米国のHIPAA（Health Insurance Portability and Accountability Act）やEUのGDPR（General Data Protection Regulation）などのデータ保護規制を遵守しなければなりません。これらの法律は、患者データを保護するための厳格なセキュリティ対策を要求しており、デジタル処方プラットフォームにとっては課題となり、コストがかかります。デジタル処方箋システムは多くの場合、電子ヘルスケア記録（EHR）や他のヘルスケアITシステムと統合する必要があるため、異なるプラットフォーム間でデータセキュリティを確保することは複雑な場合があります。システム統合に脆弱性があれば、患者データが不正アクセスにさらされる可能性があります。したがって、上記の要因が世界のデジタル処方箋市場の潜在的成長を制限している可能性があります。

当レポートでは、世界のデジタル処方箋市場について調査し、市場の概要とともに、サービスタイプ別、デリバリーモード別、地域別動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場のイントロダクションと範囲

第2章 エグゼクティブの洞察と重要なポイント

第3章 市場力学

• 影響要因
  • 促進要因
  • 抑制要因
  • 機会
  • 影響分析

第4章 戦略的洞察と業界の展望

• 市場のリーダーと先駆者
• CXOの視点
• 最新の開発とブレークスルー
• ケーススタディ/進行中の調査
• 規制と償還の情勢
• ポーターのファイブフォース分析
• サプライチェーン分析
• 特許分析
• SWOT分析
• アンメットニーズとギャップ
• 市場参入と拡大のための推奨戦略
• シナリオ分析ベストケース、ベースケース、ワーストケースの予測
• 価格分析と価格動向
• キーオピニオンリーダー

第5章 デジタル処方箋市場、サービスタイプ別

• ソリューション
• サービス

第6章 デジタル処方箋市場、デリバリーモード別

• Webおよびクラウドベースのソリューション
• オンプレミス

第7章 デジタル処方箋市場、地域別市場分析と成長機会

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他
• ラテンアメリカ
  • メキシコ
  • ブラジル
  • アルゼンチン
  • その他
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他
• 中東・アフリカ

第8章 競合情勢と市場ポジショニング

第9章 企業プロファイル

• Veradigm LLC
• Cerner Corporation（Oracle）
• DrFirst
• NXGN Management, LLC.
• MCKESSON CORPORATION
• Surescripts
• Athenahealth
• CNBC LLC.
• Practice Fusion, Inc.
• Networking Technology, Inc.

第10章 仮定と調査手法

第11章 付録

The global digital prescription market reached US$ 2.31 billion in 2024 and is expected to reach US$ 18.39 billion by 2033, growing at a CAGR of 23.4 % during the forecast period of 2025-2033.

The global digital prescription market, also known as the E-prescription market, encompasses the use of electronic systems to create, manage, store, and transmit medical prescriptions. These systems are designed to enhance prescription accuracy, minimize medication errors, and improve patient safety by integrating with electronic health records (EHRs) and pharmacy management systems.

The market is divided into two primary categories solutions and services. Solutions include integrated and standalone systems, while services encompass support & maintenance, implementation, network services, training, and education. Among these, integrated solutions dominate due to their seamless interoperability with electronic health records (EHRs) and hospital management systems, improving workflow efficiency.

Web & cloud-based solutions are experiencing rapid growth, driven by their scalability, cost-effectiveness, and remote accessibility. On-premise solutions continue to hold a strong market presence, particularly among large healthcare institutions, where data security and regulatory compliance are top priorities.

Market Dynamics: Drivers & Restraints

Increased adoption of electronic health record (EHR) Solutions

The increased adoption of electronic health record (EHR) solutions is significantly driving the growth of the global digital prescription market and is expected to drive it throughout the market forecast period.EHRs function as a centralized digital platform for storing, retrieving, and sharing patient data, allowing healthcare providers to manage medical records more efficiently. Their integration with e-prescription systems improves prescription accuracy, reduces medication errors, and enhances overall workflow efficiency.

EHRs are designed to work in sync with e-prescribing systems, ensuring that critical patient data, such as medication history, allergies, and lab results, is readily available. This real-time data accessibility helps reduce prescription errors and allows physicians to make more informed, data-driven prescribing decisions. The interoperability of EHR and e-prescription systems enhances care coordination between physicians, pharmacists, and healthcare institutions, improving overall patient safety and treatment outcomes.

Data Security and Privacy Concerns

Data security and privacy concerns will hinder the growth of the global digital prescription market, primarily due to the sensitivity of the patient information involved. Digital prescriptions rely heavily on electronic data transmission, which introduces risks of potential data breaches, unauthorized access, and cyberattacks. Prescriptions contain sensitive information, such as a patient's medication history, allergies, and personal health details. Storing and transmitting such data electronically creates concerns about the confidentiality and integrity of patient information.

Healthcare providers and technology companies must comply with data protection regulations, such as the Health Insurance Portability and Accountability Act (HIPAA) in the U.S. or the General Data Protection Regulation (GDPR) in the EU. These laws require stringent security measures to protect patient data, which can be challenging and costly for digital prescription platforms. As e-prescribing systems often need to integrate with Electronic Health Records (EHRs) and other healthcare IT systems, ensuring data security across different platforms can be complex. Any vulnerability in the system integration can expose patient data to unauthorized access. Thus, the above factors could be limiting the global digital prescription market's potential growth.

Segment Analysis

The global digital prescription market is segmented based on the type of services, delivery mode, and region.

Type of Services:

The services segment in type of services is expected to dominate the global digital prescription market with the highest market share

Services play a crucial role in the implementation, operation, and optimization of digital prescription systems. These services ensure that the technology is integrated efficiently, maintained properly, and used effectively by healthcare professionals. The main types of services offered in this market include support & maintenance, implementation, network services, and training & education.

Services include support & maintenance services, implementation services, network services, and training and education services. Implementation services focus on the deployment and integration of digital prescription systems within healthcare organizations, such as hospitals, clinics, and pharmacies. Network services support the connectivity and infrastructure necessary for real-time data exchange in digital prescription systems. These services ensure the secure transfer of prescriptions between healthcare providers, pharmacies, and other stakeholders. Training and education services ensure that healthcare professionals are well-equipped to use digital prescription systems effectively.

For instance, in September 2022, Ahmedabad-based JVS Technologies Pvt Ltd launched SoftClinic GenX, India's first zero-cost AI-powered digital prescription app. The app is designed to help doctors generate digital prescriptions within seconds and send them to patients via WhatsApp, Email, or SMS, eliminating the need for manual writing or typing. These factors have solidified the segment's position in the global digital prescription market.

Geographical Analysis

North America is expected to hold a significant position in the global digital prescription market with the highest market share

The North American digital prescription market is a rapidly growing segment of the healthcare industry, driven by various factors that promote the adoption of e-prescribing systems and digital prescription solutions. Regulatory support is one of the key factors propelling the growth of digital prescriptions in North America, particularly in the United States. The U.S. government has introduced various programs like Medicare and Medicaid incentives for the adoption of Electronic Health Records (EHRs) and e-prescribing solutions.

Continuous advancements in digital health technologies, including cloud computing, mobile applications, and artificial intelligence (AI), have significantly improved the functionality and efficiency of digital prescription systems. The integration of EHRs, telemedicine, and digital prescriptions enables healthcare providers to enhance clinical decision-making, reduce prescription errors, and provide better patient care. AI-powered systems further improve prescription accuracy and support real-time decision-making.

The adoption of digital prescriptions significantly reduces the risk of medication errors and fraud. By eliminating handwritten prescriptions, the chances of misinterpretation or illegibility are minimized, improving patient safety. E-prescribing systems also facilitate automatic checks for potential drug interactions, allergies, and contraindications, which improves prescription accuracy and prevents adverse drug events.

For instance, in August 2024, in New Jersey, Otsuka Precision Health, Inc. (OPH) and Click Therapeutics, Inc. officially launched Rejoyn, the first FDA-cleared prescription digital therapeutic (DTx) for major depressive disorder (MDD). Cleared in March 2024, Rejoyn is designed as an adjunct to clinician-managed outpatient care for adults (22+ years) who are already taking antidepressant medication. Thus, the above factors are consolidating the region's position as a dominant force in the global digital prescription market.

Competitive Landscape

The major global players in the digital prescription market include Veradigm LLC, Cerner Corporation (Oracle), DrFirst, NXGN Management, LLC., MCKESSON CORPORATION, Surescripts, Athenahealth, CNBC LLC., Practice Fusion, Inc., and Networking Technology, Inc., among others.

Key Developments

• In November 2024, Click Therapeutics launched software-enhanced drug therapies under its new click SE offering. This initiative aims to integrate clinically validated digital therapeutics with traditional pharmacotherapy, enhancing treatment efficacy and patient outcomes. The move aligns with evolving FDA guidance on Prescription Drug-Use Related Software (PDURS), which supports using software to provide clinically meaningful benefits beyond conventional drug therapies.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials and product pipelines and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzed product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global digital prescription market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

• 1.1. Objectives of the Report
• 1.2. Report Coverage & Definitions
• 1.3. Report Scope

2. Executive Insights and Key Takeaways

• 2.1. Market Highlights and Strategic Takeaways
• 2.2. Key Trends and Future Projections
• 2.3. Snippet by Type of Services
• 2.4. Snippet by Delivery Mode
• 2.5. Snippet by Region

3. Dynamics

• 3.1. Impacting Factors
  • 3.1.1. Drivers
    • 3.1.1.1. Increased Adoption of Electronic Health Record (EHR) Solutions
    • 3.1.1.2. Rising Adoption of Cloud-Based Solutions
  • 3.1.2. Restraints
    • 3.1.2.1. Data Security and Privacy Concerns
    • 3.1.2.2. High Initial Investment Costs
  • 3.1.3. Opportunity
    • 3.1.3.1. Growing Adoption of Telemedicine
  • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

• 4.1. Market Leaders and Pioneers
  • 4.1.1. Emerging Pioneers and Prominent Players
  • 4.1.2. Established leaders with largest selling Brand
  • 4.1.3. Market leaders with established Product
• 4.2. CXO Perspectives
• 4.3. Latest Developments and Breakthroughs
• 4.4. Case Studies/Ongoing Research
• 4.5. Regulatory and Reimbursement Landscape
  • 4.5.1. North America
  • 4.5.2. Europe
  • 4.5.3. Asia Pacific
  • 4.5.4. Latin America
  • 4.5.5. Middle East & Africa
• 4.6. Porter's Five Forces Analysis
• 4.7. Supply Chain Analysis
• 4.8. Patent Analysis
• 4.9. SWOT Analysis
• 4.10. Unmet Needs and Gaps
• 4.11. Recommended Strategies for Market Entry and Expansion
• 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
• 4.13. Pricing Analysis and Price Dynamics
• 4.14. Key Opinion Leaders

5. Digital Prescription Market, By Type of Services

• 5.1. Introduction
  • 5.1.1. Analysis and Y-o-Y Growth Analysis (%), By Type of Services
  • 5.1.2. Market Attractiveness Index By Type of Services
• 5.2. Solutions*
  • 5.2.1. Introduction
  • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.2.3. Integrated Solutions
  • 5.2.4. Standalone Solutions
• 5.3. Services
  • 5.3.1. Support & Maintenance Services
  • 5.3.2. Implementation Services
  • 5.3.3. Network Services
  • 5.3.4. Training And Education Services

6. Digital Prescription Market By Delivery Mode

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
  • 6.1.2. Market Attractiveness Index By Delivery Mode
• 6.2. Web and Cloud-Based Solutions*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. On Premise

7. Digital Prescription Market, By Regional Market Analysis and Growth Opportunities

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 7.1.2. Market Attractiveness Index, By Region
• 7.2. North America
  • 7.2.1. Introduction
  • 7.2.2. Key Region-Specific Dynamics
  • 7.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Services
  • 7.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
  • 7.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 7.2.5.1. U.S.
    • 7.2.5.2. Canada
• 7.3. Europe
  • 7.3.1. Introduction
  • 7.3.2. Key Region-Specific Dynamics
  • 7.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Services
  • 7.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
  • 7.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 7.3.5.1. Germany
    • 7.3.5.2. U.K.
    • 7.3.5.3. France
    • 7.3.5.4. Spain
    • 7.3.5.5. Italy
    • 7.3.5.6. Rest of Europe
• 7.4. Latin America
  • 7.4.1. Introduction
  • 7.4.2. Key Region-Specific Dynamics
  • 7.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Services
  • 7.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
  • 7.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 7.4.5.1. Mexico
    • 7.4.5.2. Brazil
    • 7.4.5.3. Argentina
    • 7.4.5.4. Rest of Latin America
• 7.5. Asia-Pacific
  • 7.5.1. Introduction
  • 7.5.2. Key Region-Specific Dynamics
  • 7.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Services
  • 7.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
  • 7.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 7.5.5.1. China
    • 7.5.5.2. India
    • 7.5.5.3. Japan
    • 7.5.5.4. South Korea
    • 7.5.5.5. Rest of Asia-Pacific
• 7.6. Middle East and Africa
  • 7.6.1. Introduction
  • 7.6.2. Key Region-Specific Dynamics
  • 7.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Services
  • 7.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode

8. Competitive Landscape and Market Positioning

• 8.1. Competitive Overview and Key Market Players
• 8.2. Market Share Analysis and Positioning Matrix
• 8.3. Strategic Partnerships, Mergers & Acquisitions
• 8.4. Key Developments in Product Portfolios and Innovations
• 8.5. Company Benchmarking

9. Company Profiles

• 9.1. Veradigm LLC*
  • 9.1.1. Company Overview
  • 9.1.2. Product Portfolio
    • 9.1.2.1. Product Description
    • 9.1.2.2. Product Key Performance Indicators (KPIs)
    • 9.1.2.3. Historic and Forecasted Product Sales
    • 9.1.2.4. Product Sales Volume
  • 9.1.3. Financial Overview
    • 9.1.3.1. Company Revenue's
    • 9.1.3.2. Geographical Revenue Shares
    • 9.1.3.3. Revenue Forecasts
  • 9.1.4. Key Developments
    • 9.1.4.1. Mergers & Acquisitions
    • 9.1.4.2. Key Product Development Activities
    • 9.1.4.3. Regulatory Approvals, etc.
  • 9.1.5. SWOT Analysis
• 9.2. Cerner Corporation (Oracle)
• 9.3. DrFirst
• 9.4. NXGN Management, LLC.
• 9.5. MCKESSON CORPORATION
• 9.6. Surescripts
• 9.7. Athenahealth
• 9.8. CNBC LLC.
• 9.9. Practice Fusion, Inc.
• 9.10. Networking Technology, Inc.

LIST NOT EXHAUSTIVE

10. Assumption and Research Methodology

• 10.1. Data Collection Methods
• 10.2. Data Triangulation
• 10.3. Forecasting Techniques
• 10.4. Data Verification and Validation

11. Appendix

• 11.1. About Us and Services
• 11.2. Contact Us